相关实验视频
Updated: Jun 24, 2025

08:15
Data Communication Based on MQTT in a Polymer Extrusion Process
Published on: July 15, 2022
3.4K
通过物联网 (IoT) 实现沙特阿拉伯药品供应链的区块链
1Department of Computer Science, College of Computing and Information Technology, Shaqra University, Shaqra, Saudi Arabia.
PeerJ. Computer science
|June 10, 2024
概括
区块链和物联网集成可以提高药物供应链的可追溯性和可靠性. 这项技术确保了药物的安全,透明和高效的分发,改善了公共卫生结果.
科学领域:
- 制药科学 制药科学
- 计算机科学 计算机科学
- 公共卫生 公共卫生
背景情况:
- 药物供应链的低效率和缺乏可追溯性导致药物不可用,并危及公共卫生.
- 目前的系统正在与信息丢失,药物储存的不充分跟踪以及利益相关者之间的透明度不足作斗争.
- 供应链各方之间的利益冲突可能会阻碍公平的药物分销.
研究的目的:
- 用区块链和物联网技术提出可靠药品供应链的新型模型.
- 解决药物可追溯性,信息共享和药物存储方面的挑战.
- 提高药品分销的安全性,透明度和成本效益.
主要方法:
- 开发基于代币的区块链模型,以实现分散的药物可追溯性.
- 物联网 (IoT) 设备的集成,用于连续的数据供应和系统监控.
- 利用区块链固有的数据完整性和来源特征用于供应链管理.
主要成果:
- 拟议的模型为药物供应链交易提供了去中心化和透明的分类账.
- 物联网设备确保实时,可靠的数据输入,提高系统可靠性.
- 区块链技术为制药提供了强大的数据完整性和来源跟踪.
结论:
- 与物联网集成的基于代币的区块链系统为药物供应链管理提供了安全,经济高效和可靠的解决方案.
- 这种方法显著改善了药物可追溯性,解决了关键的公共卫生问题.
- 分散的信息和增强的数据完整性是药品分销的关键好处.
相关概念视频
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Drug Control Governance: Regulatory Bodies and Their Impact
153
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
153
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Drug Distribution: Volume of Distribution
5.0K
The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
5.0K
Tissue-Drug Binding: Localization of Drugs and its Significance
79
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
79
Structure-Activity Relationships and Drug Design
699
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
699

